Loading…
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
Pandit, Anuja, Bhalani, Nirav, Bhushan, B.L. Shashi, Koradia, Parshottam, Gargiya, Shweta, Bhomia, Vinay, Kansagra, Kevinkumar
Published in International journal of infectious diseases (01.04.2021)
Published in International journal of infectious diseases (01.04.2021)
Get full text
Journal Article
Loading…
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study
Bhushan B L, Shashi, Wanve, Sunil, Koradia, Parshottam, Bhomia, Vinay, Soni, Pravin, Chakraborty, Sisir, Khobragade, Akash, Joshi, Shashank, Mendiratta, Sanjeev Kumar, Kansagra, Kevin Kumar, Parihar, Anurag, Sharma, Sunil, Patel, Jatin
Published in International journal of infectious diseases (01.10.2021)
Published in International journal of infectious diseases (01.10.2021)
Get full text
Journal Article
Loading…
Novel long‐acting ropeginterferon alfa‐2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial
Huang, Yi‐Wen, Qin, Albert, Fang, Jane, Wang, Ting‐Fang, Tsai, Chung‐Wei, Lin, Ko‐Chung, Teng, Ching‐Leou, Larouche, Richard
Published in British journal of clinical pharmacology (01.05.2022)
Published in British journal of clinical pharmacology (01.05.2022)
Get full text
Journal Article
Loading…
Tyrosine metabolism during interferon-alpha administration: Association with fatigue and CSF dopamine concentrations
Felger, Jennifer C., Li, Li, Marvar, Paul J., Woolwine, Bobbi J., Harrison, David G., Raison, Charles L., Miller, Andrew H.
Published in Brain, behavior, and immunity (01.07.2013)
Published in Brain, behavior, and immunity (01.07.2013)
Get full text
Journal Article
Loading…
Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder
Su, Kuan-Pin, Lai, Hsueh-Chou, Peng, Cheng-Yuan, Su, Wen-Pang, Chang, Jane Pei-Chen, Pariante, Carmine M.
Published in Brain, behavior, and immunity (01.08.2019)
Published in Brain, behavior, and immunity (01.08.2019)
Get full text
Journal Article
Loading…
Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C: A Nationwide Survey in Taiwan
Yu, Ming-Lung, Yeh, Ming-Lun, Tsai, Pei-Chien, Huang, Ching-I., Huang, Jee-Fu, Huang, Chung-Feng, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Lin, Wen-Yi, Hou, Nai-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Chang, Wen-Yu
Published in Medicine (Baltimore) (01.04.2015)
Published in Medicine (Baltimore) (01.04.2015)
Get full text
Journal Article
Loading…
Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons
Chung, Raymond T, Andersen, Janet, Volberding, Paul, Robbins, Gregory K, Liu, Tun, Sherman, Kenneth E, Peters, Marion G, Koziel, Margaret J, Bhan, Atul K, Alston, Beverly, Colquhoun, Dodi, Nevin, Tom, Harb, George, van der Horst, Charles
Published in The New England journal of medicine (29.07.2004)
Published in The New England journal of medicine (29.07.2004)
Get full text
Journal Article
Loading…
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?
Capuron, Lucile, Fornwalt, Fiona B., Knight, Bettina T., Harvey, Philip D., Ninan, Philip T., Miller, Andrew H.
Published in Journal of affective disorders (01.12.2009)
Published in Journal of affective disorders (01.12.2009)
Get full text
Journal Article
Loading…
Depression-free after Interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan
Sun, Ching-Fang, Chiu, Wei-Che, Chen, Pau-Chung, Chang, Hui-Chih, Guu, Ta-Wei, Shityakov, Sergey, Miller, Andrew H., Felger, Jennifer C., Chang, Jane Pei-Chen, Su, Kuan-Pin
Published in Brain, behavior, and immunity (01.08.2020)
Published in Brain, behavior, and immunity (01.08.2020)
Get full text
Journal Article
Loading…
Comparative Evaluation of Tacrolimus Versus Interferon Alpha-2b Eye Drops in the Treatment of Vernal Keratoconjunctivitis: A Randomized, Double-Masked Study
Zanjani, Habibollah, Aminifard, Mohammad Naim, Ghafourian, Abdolhossein, Pourazizi, Mohsen, Maleki, Alireza, Arish, Mohammed, Shahrakipoor, Mahnaz, Rohani, Mohammad Reza, Abrishami, Mojtaba, Khafri Zare, Ehsan, Barzegar Jalali, Farhad
Published in Cornea (01.06.2017)
Published in Cornea (01.06.2017)
Get more information
Journal Article
Loading…
Loading…
Loading…
Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: Relationship with interleukin-6
Lotrich, Francis E., Sears, Barry, McNamara, Robert K.
Published in Brain, behavior, and immunity (01.07.2013)
Published in Brain, behavior, and immunity (01.07.2013)
Get full text
Journal Article
Loading…
Neuropsychiatric adverse effects of interferon-α: Recognition and management
RAISON, Charles L, DEMETRASHVILI, Marina, CAPURON, Lucile, MILLER, Andrew H
Published in CNS drugs (01.01.2005)
Published in CNS drugs (01.01.2005)
Get full text
Journal Article
Loading…
Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response
Kamal, Sanaa M, Fouly, Amr E, Kamel, Refaat R, Hockenjos, Bridgette, Al Tawil, Ahmed, Khalifa, Khalifa E, He, Qi, Koziel, Margaret J, El Naggar, Khairy M, Rasenack, Jens, Afdhal, Nezam H
Published in Gastroenterology (New York, N.Y. 1943) (01.03.2006)
Published in Gastroenterology (New York, N.Y. 1943) (01.03.2006)
Get more information
Journal Article
Loading…
Loading…
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
Lindsay, Karen L., Trepo, Christian, Heintges, Tobias, Shiffman, Mitchell L., Gordon, Stuart C., Hoefs, John C., Schiff, Eugene R., Goodman, Zachary D., Laughlin, Mark, Yao, Ruji, Albrecht, Janice K.
Published in Hepatology (Baltimore, Md.) (01.08.2001)
Published in Hepatology (Baltimore, Md.) (01.08.2001)
Get full text
Journal Article
Loading…
Loading…
The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial
Huang, Wenqi, Kang, Yanneng, Zhao, Yajun, Yang, Jiao, Dai, Changjuan, Wu, Weibing, Xu, Jinchao, Jin, Wen, Wu, Xiaolu, Zhou, Qing
Published in BMC pharmacology & toxicology (12.05.2025)
Published in BMC pharmacology & toxicology (12.05.2025)
Get full text
Journal Article
Loading…
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial
Jonas, Maureen M., Balistreri, William, Gonzalez-Peralta, Regino P., Haber, Barbara, Lobritto, Steven, Mohan, Parvathi, Molleston, Jean P., Murray, Karen F., Narkewicz, Michael R., Rosenthal, Philip, Schwarz, Kathleen B., Barton, Bruce A., Shepherd, John A., Mitchell, Paul D., Duggan, Christopher
Published in Hepatology (Baltimore, Md.) (01.08.2012)
Published in Hepatology (Baltimore, Md.) (01.08.2012)
Get full text
Journal Article